Activity of Tigecycline in Combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-Producing Enterobacteriaceae in a Murine Thigh Infection Model

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2013-09-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.00891-13PMID 24060874PMCID PMC3837854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and Laboratory Standards Institute.

  2013cited by this paper
• Tigecycline Displays In Vivo Bactericidal Activity against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae after 72-Hour Exposure Period

  2012cited by this paper
• Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens

  2012cited by this paper
• Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects

  2012cited by this paper
• Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing Enterobacteriaceae

  2012influential reference
• Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports

  2012cited by this paper
• In Vitro and In Vivo Synergistic Effects of Cryptdin 2 and Ampicillin against Salmonella

  2011cited by this paper
• Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.

  2011influential reference
• Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.

  2010cited by this paper
• fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

  2010cited by this paper
• Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii

  2010cited by this paper
• Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae

  2009cited by this paper
• The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

  2009influential reference
• Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.

  2009cited by this paper
• Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem.

  2009cited by this paper
• Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.

  2009influential reference
• In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing.

  2009cited by this paper
• Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi

  2009cited by this paper
• Activities of Clindamycin, Daptomycin, Doxycycline, Linezolid, Trimethoprim-Sulfamethoxazole, and Vancomycin against Community-Associated Methicillin-Resistant Staphylococcus aureus with Inducible Clindamycin Resistance in Murine Thigh Infection and In Vitro Pharmacodynamic Models

  2008cited by this paper
• In Vitro and In Vivo Evaluations of Oxacillin Efficiency against mecA-Positive Oxacillin-Susceptible Staphylococcus aureus

  2008cited by this paper
• First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests.

  2008cited by this paper
• In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.

  2008cited by this paper
• Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone.

  2008cited by this paper
• Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus.

  2007cited by this paper
• Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis.

  2007cited by this paper
• Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.

  2006cited by this paper
• In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis.

  2006cited by this paper
• Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

  2005cited by this paper
• Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

  2004cited by this paper
• In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid)

  2002cited by this paper
• Performance standards for antimicrobial susceptibility testing

  2001cited by this paper

• Colistin antibacterial activity, clinical effectiveness, and mechanisms of intrinsic and acquired resistance.

  2025cites this paper
• Detection and Evaluation of Multidrug Resistance and the Presence of Virulence Genes Related to the Formation of ompA, epsA, and Bap Biofilms in Clinical Isolates of Acinetobacter baumannii in Tehran, Iran

  2025cites this paper
• Sub-minimum inhibitory concentrations (sub-MICs) of colistin on Acinetobacter baumannii biofilm formation potency, adherence, and invasion to epithelial host cells: an experimental study in an Iranian children’s referral hospital

  2024cites this paper
• Highly Sensitive In Vivo Imaging of Bacterial Infections with a Hydrophilicity‐Switching, Self‐Immobilizing, Near‐Infrared Fluorogenic β‐Lactamase Probe Enriched within Bacteria

  2024cites this paper
• In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales

  2023cites this paper
• Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review

  2023cites this paper
• Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors

  2023cites this paper
• Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?

  2023cites this paper
• Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae: A Propensity Score-Matched Cohort Study

  2023cites this paper
• The in vitro and in vivo potential of metal-chelating agents as metallo-beta-lactamase inhibitors against carbapenem-resistant Enterobacterales.

  2022cites this paper
• Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?

  2021influential citation
• EFFICACY OF TIGECYCLINE SINGLE OR IN COMBINATION FOR EXPERIMENTAL INFECTIONS BY KPC CARBAPENEMASE-PRODUCING KLEBSIELLA PNEUMONIAE.

  2021cites this paper
• In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.

  2021cites this paper
• Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in In Vitro and In Vivo Studies

  2020cites this paper
• Synergistic Effect of a Pleuromutilin Derivative with Tetracycline against Streptococcus suis In Vitro and in the Neutropenic Thigh Infection Model

  2020cites this paper
• The efficacy of mesenchymal stem cell therapy in experimental sepsis induced by carbapenem-resistant K. pneumoniae in neutropenic mice model

  2020cites this paper
• Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.

  2019cites this paper
• Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae

  2019cites this paper
• Rational Combinations of Polymyxins with Other Antibiotics.

  2019cites this paper
• IN VITRO AND IN VIVO EVALUATION OF METAL- CHELATING AGENTS AS NOVEL METALLO BETA-LACTAMASE INHIBITORS AGAINST CARBAPENEM -RESISTANT ENTEROBACTERIACEAE. 2018

  2019cites this paper
• Association Between Biofilm Formation, Structure, and the Expression Levels of Genes Related to biofilm formation and Biofilm-Specific Resistance of Acinetobacter baumannii Strains Isolated from Burn Infection in Ahvaz, Iran

  2019cites this paper
• General Assembly, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections.

  2019cites this paper
• Clinical relevance of in vitro synergistic activity of antibiotics for multidrug-resistant Gram-negative infections: A systematic review.

  2019cites this paper
• Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection

  2019cites this paper
• Optimizing therapy in CRE infections.

  2018cites this paper
• Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Validation of Scores and Proposal for Management

  2018cites this paper
• Etiologic analysis of Chinese patients with agranulocytosis and hematopathies infected with resistant bacteria: Antibacterial effect of tigecycline

  2018cites this paper
• Biofilm Formation in Klebsiella pneumoniae Bacteremia Strains Was Found to be Associated with CC23 and the Presence of wcaG

  2018cites this paper
• Carbapenem-resistant Enterobacteriaceae: recent updates and treatment strategies

  2018cites this paper
• Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae

  2018cites this paper
• choice and duration of antibiotic therapy in polymicrobial surgical site infection / periprosthetic joint infection ( SSI / PJI ) ?

  2018cites this paper
• Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates

  2018cites this paper
• Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.

  2017cites this paper
• Clinical translation of polymyxin-based combination therapy: Facts, challenges and future opportunities.

  2017cites this paper
• In Vitro and In Vivo Activity of Single and Dual Antimicrobial Agents Against KPC-producing Klebsiella pneumoniae

  2017cites this paper
• Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates

  2017cites this paper
• New Polymyxin B Dosing Strategies To Fortify Old Allies in the War against KPC-2-Producing Klebsiella pneumoniae

  2017cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Colistin

  2017cites this paper
• Combination therapy for extensively-drug resistant gram-negative bacteria

  2017cites this paper
• Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems

  2017cites this paper
• In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates

  2016cites this paper
• Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time–Kill Method

  2016cites this paper
• Synergistic combinations of polymyxins.

  2016cites this paper
• Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model

  2016cites this paper
• Drug treatments for prosthetic joint infections in the era of multidrug resistance

  2016cites this paper
• Polymyxin Pharmacokinetics and Pharmacodynamics

  2016cites this paper
• Tigecycline: Alone or in combination?

  2016influential citation
• Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance

  2015cites this paper
• Carbapenemase-Producing Enterobacteriaceae

  2015cites this paper
• Bacterial Infections and Drug Resistant Pathogens ( H Wisplinghoff , Section Editor ) Epidemiology and Treatment of MDR Enterobacteriaceae

  2015cites this paper
• Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection.

  2015cites this paper
• Activity of Antimicrobial Combinations against KPC-2-Producing Klebsiella pneumoniae in a Rat Model and Time-Kill Assay

  2015cites this paper
• Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria

  2015cites this paper
• Re-defining tigecycline therapy.

  2015cites this paper
• In Vitro and In Vivo Activities of Tigecycline-Colistin Combination Therapies against Carbapenem-Resistant Enterobacteriaceae

  2014cites this paper
• Enterobacteriaceae against Carbapenem-Resistant Therapies Tigecycline-Colistin Combination Activities of In Vivo and In Vitro

  2014cites this paper
• Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens.

  2014cites this paper
• Carbapenem-Resistant Klebsiella Pneumoniae Osteomyelitis and Soft Tissue Infections: A Descriptive Case Series

  2014cites this paper